SG11202002687UA - Immunomodulatory oligosaccharides - Google Patents
Immunomodulatory oligosaccharidesInfo
- Publication number
- SG11202002687UA SG11202002687UA SG11202002687UA SG11202002687UA SG11202002687UA SG 11202002687U A SG11202002687U A SG 11202002687UA SG 11202002687U A SG11202002687U A SG 11202002687UA SG 11202002687U A SG11202002687U A SG 11202002687UA SG 11202002687U A SG11202002687U A SG 11202002687UA
- Authority
- SG
- Singapore
- Prior art keywords
- immunomodulatory
- oligosaccharides
- immunomodulatory oligosaccharides
- Prior art date
Links
- 230000002519 immonomodulatory effect Effects 0.000 title 1
- 229920001542 oligosaccharide Polymers 0.000 title 1
- 150000002482 oligosaccharides Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/306—Foods, ingredients or supplements having a functional effect on health having an effect on bone mass, e.g. osteoporosis prevention
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/28—Oligosaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762567865P | 2017-10-04 | 2017-10-04 | |
| PCT/US2018/054433 WO2019071021A2 (en) | 2017-10-04 | 2018-10-04 | Immunomodulatory oligosaccharides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202002687UA true SG11202002687UA (en) | 2020-04-29 |
Family
ID=65994796
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202002687UA SG11202002687UA (en) | 2017-10-04 | 2018-10-04 | Immunomodulatory oligosaccharides |
Country Status (9)
| Country | Link |
|---|---|
| US (7) | US20200237793A1 (en) |
| EP (1) | EP3691658A4 (en) |
| KR (1) | KR20200084864A (en) |
| CN (1) | CN111356461A (en) |
| AU (1) | AU2018346500A1 (en) |
| CA (1) | CA3076920A1 (en) |
| MX (2) | MX2020004133A (en) |
| SG (1) | SG11202002687UA (en) |
| WO (1) | WO2019071021A2 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112165947A (en) * | 2018-05-31 | 2021-01-01 | 格礼卡姆股份公司 | HMO mixtures for the treatment of autoimmune diseases |
| AU2020272575A1 (en) * | 2019-04-09 | 2021-11-18 | Intrinsic Medicine, Inc. | Immunomodulatory oligosaccharides for the treatment of pain |
| WO2024121171A1 (en) * | 2022-12-05 | 2024-06-13 | Inbiose N.V. | Sialylated saccharide for use in the prevention or treatment of an inflammatory disease and/or autoimmune disease |
| CN117919262A (en) * | 2022-12-12 | 2024-04-26 | 天津市肿瘤医院（天津医科大学肿瘤医院） | Application of 2' -fucosyllactose as antitumor auxiliary drug and PD-1 resisting drug in preparation of drug for treating colon cancer |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5164374A (en) * | 1990-12-17 | 1992-11-17 | Monsanto Company | Use of oligosaccharides for treatment of arthritis |
| US20050245557A1 (en) * | 2003-10-15 | 2005-11-03 | Pain Therapeutics, Inc. | Methods and materials useful for the treatment of arthritic conditions, inflammation associated with a chronic condition or chronic pain |
| WO2007114683A1 (en) * | 2006-03-30 | 2007-10-11 | N.V. Nutricia | Milk oligosaccharides for stimulating the immune system |
| ES2651067T3 (en) * | 2009-07-06 | 2018-01-24 | Children's Hospital Medical Center | Inhibition of inflammation with milk oligosaccharides |
| GB0922066D0 (en) * | 2009-12-17 | 2010-02-03 | Univ Belfast | Modulator |
| NL2004201C2 (en) * | 2010-02-05 | 2011-08-08 | Friesland Brands Bv | Use of sialyl oligosaccharides to modulate the immune system. |
| SG191798A1 (en) * | 2010-12-31 | 2013-08-30 | Abbott Lab | Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota |
| WO2013154725A1 (en) * | 2012-04-13 | 2013-10-17 | Trustees Of Boston College | Prebiotic compositions and methods of use |
| WO2016029113A1 (en) * | 2014-08-22 | 2016-02-25 | Abbott Laboratories | Methods of increasing endogenous production of beta-hydroxy-beta-methylbutyrate |
| JP6696056B1 (en) * | 2017-01-23 | 2020-05-20 | シノビゼン・カンパニー・リミテッド | Composition for preventing or treating degenerative arthritis containing sialyllactose or a salt thereof as an active ingredient |
-
2018
- 2018-10-04 CA CA3076920A patent/CA3076920A1/en active Pending
- 2018-10-04 MX MX2020004133A patent/MX2020004133A/en unknown
- 2018-10-04 KR KR1020207010098A patent/KR20200084864A/en not_active Application Discontinuation
- 2018-10-04 SG SG11202002687UA patent/SG11202002687UA/en unknown
- 2018-10-04 AU AU2018346500A patent/AU2018346500A1/en active Pending
- 2018-10-04 EP EP18864540.2A patent/EP3691658A4/en active Pending
- 2018-10-04 WO PCT/US2018/054433 patent/WO2019071021A2/en unknown
- 2018-10-04 CN CN201880073029.9A patent/CN111356461A/en active Pending
-
2020
- 2020-04-03 US US16/840,026 patent/US20200237793A1/en not_active Abandoned
- 2020-04-03 US US16/840,059 patent/US20200230161A1/en not_active Abandoned
- 2020-07-13 MX MX2023006458A patent/MX2023006458A/en unknown
-
2021
- 2021-04-15 US US17/231,336 patent/US20210236526A1/en not_active Abandoned
- 2021-04-15 US US17/231,367 patent/US20210236527A1/en not_active Abandoned
-
2023
- 2023-01-23 US US18/100,204 patent/US20230149433A1/en active Pending
- 2023-02-09 US US18/107,936 patent/US20230181609A1/en active Pending
- 2023-02-17 US US18/111,103 patent/US20230201228A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA3076920A1 (en) | 2019-04-11 |
| EP3691658A4 (en) | 2021-06-23 |
| AU2018346500A1 (en) | 2020-04-02 |
| CN111356461A (en) | 2020-06-30 |
| US20200237793A1 (en) | 2020-07-30 |
| WO2019071021A2 (en) | 2019-04-11 |
| WO2019071021A3 (en) | 2020-04-02 |
| US20230201228A1 (en) | 2023-06-29 |
| KR20200084864A (en) | 2020-07-13 |
| MX2020004133A (en) | 2020-08-13 |
| US20200230161A1 (en) | 2020-07-23 |
| US20210236526A1 (en) | 2021-08-05 |
| US20230181609A1 (en) | 2023-06-15 |
| US20210236527A1 (en) | 2021-08-05 |
| MX2023006458A (en) | 2023-06-14 |
| EP3691658A2 (en) | 2020-08-12 |
| US20230149433A1 (en) | 2023-05-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201912537PA (en) | Exoskeleton | |
| GB201701829D0 (en) | Device | |
| GB201709597D0 (en) | Device | |
| GB201704627D0 (en) | Round-Counting Device | |
| GB201720531D0 (en) | Device | |
| SG11202002687UA (en) | Immunomodulatory oligosaccharides | |
| ZA201907266B (en) | Excrement-drying device | |
| GB201706302D0 (en) | Meical device | |
| EP3666132C0 (en) | Beverage-manufacturing device | |
| PT3620835T (en) | Cable-retention device | |
| GB201716031D0 (en) | Device | |
| GB201708224D0 (en) | Device | |
| HUE063708T2 (en) | Container-exchanging device | |
| GB201717627D0 (en) | Connection arrangement | |
| GB201709726D0 (en) | Device | |
| GB201709656D0 (en) | Device | |
| GB201709644D0 (en) | Device | |
| GB201702466D0 (en) | Photocoltaic device | |
| IL271385A (en) | Cell-sealing device | |
| HK1258410A1 (en) | Device | |
| PL3579992T3 (en) | Panel-retaining device | |
| GB201718538D0 (en) | u | |
| GB201709050D0 (en) | Device | |
| GB201712952D0 (en) | Immunomodulatory agent | |
| GB2577816B (en) | Device |